FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New clinical recommendation for local treatment of oligometastatic lung cancer.

2.

Charles III, King of Kings, is Cancerous.

3.

Surgery may not be necessary to treat invasive breast cancer

4.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

5.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot